Latest Breaking News On - Safety considerations with - Page 1 : comparemela.com

Mazyar Shadman, MD, MPH, details the efficacy of BTK inhibitors in the frontline treatment of CLL as well as safety considerations in the relapsed/refractory setting.

United statesNorth carolinaUniversity of washingtonAlan skarbnikMazyar shadmanAmerican society of hematology annual meeting expositionNovant health in charlotteInternational conference on malignant lymphomaOncology divisionUniversity of washington school medicineInnovators networkOnclive scientific interchangeWorkshop chronic lymphocytic leukemiaLatest dataClinical practiceInnovators network endowed chair